Biogen to Acquire Apellis Pharmaceuticals for $5.6 Billion

Date:




Biogen agreed to acquire Apellis Pharmaceuticals for approximately $5.6 billion, expanding its portfolio in immunology and rare-disease medicines.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Bunnie Xo Opens Up About Life After Jelly Roll Divorce

Bunnie Xo has a lot going on these days,...

Seahawks’ Bud Clark, Mason Richman out long-term with injuries

Brady HendersonAug 23, 2026, 09:36 PM ETCloseBrady Henderson is...

Oregon quintuple murder suspect found dead in Washington

Suspect found dead after 5 bodies discovered in rural...